Current methods for the synthesis of homogeneous antibody–drug conjugates
Open Access
- 1 November 2015
- journal article
- review article
- Published by Elsevier in Biotechnology Advances
- Vol. 33 (6), 775-784
- https://doi.org/10.1016/j.biotechadv.2015.05.001
Abstract
No abstract availableKeywords
Funding Information
- National Science Centre, Poland (DEC-2013/08/S/NZ1/00845, 2011/02/A/NZ1/00066)
This publication has 81 references indexed in Scilit:
- Synthesis of site-specific antibody-drug conjugates using unnatural amino acidsProceedings of the National Academy of Sciences, 2012
- Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's LymphomaJournal of Clinical Oncology, 2012
- Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II StudyJournal of Clinical Oncology, 2012
- Site-specific chemical protein conjugation using genetically encoded aldehyde tagsNature Protocols, 2012
- Disulfide bond structures of IgG moleculesmAbs, 2012
- Molecularly Defined Antibody Conjugation through a Selenocysteine InterfaceBiochemistry, 2009
- Site Specific Conjugation of Fluoroprobes to the Remodeled Fc N-Glycans of Monoclonal Antibodies Using Mutant Glycosyltransferases: Application for Cell Surface Antigen DetectionBioconjugate Chemistry, 2009
- Anti-CD30 diabody-drug conjugates with potent antitumor activityMolecular Cancer Therapeutics, 2008
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic indexNature Biotechnology, 2008
- Structural characterization of the maytansinoid–monoclonal antibody immunoconjugate, huN901–DM1, by mass spectrometryProtein Science, 2005